Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CANTREAT: Anidulafungin for Candida in VAP
NCT00934934Phase 2Terminated
- Start
- Apr 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of anidulafungin in ventilator-associated pneumonia (VAP). Started Apr 2010; status: terminated.
02
Drugs
anidulafungin
03
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT00934934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00934934.